HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

882.626

+4.1390.47%

Number of Gainers:7

Number of Losers:9

Number of Flat:1

PE:- -

High:884.571

Open:878.433

Low:868.104

Close:878.487

Volume:122.04M

Turnover:908.24M

Market Cap:596.15B

Float Cap:494.00B

Loading ...

Kintor Pharma Completes 52-Week Human Safety Trial of Skin-Whitening Ingredient KT-939

Chinese Automakers Shift Toward Deep Overseas Expansion With Local Manufacturing and Dealer Networks

Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares

THOMSON REUTERS

Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale

Dizhe Pharma Stock Drops Over 5% After Insider Sell-Off Plan; Company Affirms Long-Term Confidence

ALEBUND-B (09637) H Shares Set to Join Stock Connect and Hang Seng Composite Index

Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping

Junshi Biosciences Schedules 2026 Interim Results Conference Call

Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment

China Traditional Chinese Medicine Says NMPA Approves Launch of Xingpi Jieyu Tablets for Depression

China Traditional Chinese Medicine Holdings - Nmpa Approves Xingpi Jieyu Tablets for Marketing

THOMSON REUTERS

Sinopharm Group Stock Advances 1.5% in Hong Kong

JD Health International Stock Rallies 2.9% in Hong Kong

Alibaba Health Information Technology Stock Climbs 3.3% in Hong Kong

DBS lifts BYD Electronic price target to HK$40, reiterates 'Buy'

Healthcare Sector Poised for Continued Recovery, Buoyed by Strong Innovation and Upgraded Earnings Forecasts

Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B

Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug

MT Newswires Live

Baiyunshan Announces Cash Dividend Distribution for First Half of 2026

Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/BK1515/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":882.6258,"timestamp":1789621870645,"preClose":878.48724,"halted":0,"volume":122041286,"delay":0,"changeRate":0.004711,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":4.13855,"latestTime":"09-17 13:11:11","open":878.4325,"high":884.57117,"low":868.10425,"amount":908238041,"amplitude":0.018745,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789632600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789608600000,1789617600000],[1789621200000,1789632000000]],"pbRate":1.317311,"peRate":17.071131,"turnoverRate":0.001672,"increases":7,"decrements":9,"flats":1,"marketCap":596154072832,"floatMarketCap":494003331136},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":884.57117,"amplitude":0.018745,"preClose":878.48724,"low":868.10425,"pbRate":"1.317311","latestPrice":882.6258,"volume":122041286,"delay":0,"open":878.4325,"prevYearClose":1190.107,"prevWeekClose":878.789,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":890.408,"twentyDayClose":941.274,"sixtyDayClose":813.549,"secType":"PLATE","market":"HK","turnoverRate":0.001672,"peRate":17.071131,"marketCap":596154072832,"floatMarketCap":494003331136,"timestamp":1789621870645,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":7,"down":9,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2665438367","title":"Kintor Pharma Completes 52-Week Human Safety Trial of Skin-Whitening Ingredient KT-939","url":"https://stock-news.laohu8.com/highlight/detail?id=2665438367","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665438367?lang=en_us&edition=fundamental","pubTime":"2026-09-07 06:08","pubTimestamp":1788732492,"startTime":"0","endTime":"0","summary":"Kintor Pharma completes 52-week human safety trial of skin-whitening ingredient KT-939Kintor Pharmaceutical completed a 52-week long-term human safety trial of KT-939 on Sept. 4, 2026.Preliminary resu","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nNDL4qRNq1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","09939","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115611725","title":"Chinese Automakers Shift Toward Deep Overseas Expansion With Local Manufacturing and Dealer Networks","url":"https://stock-news.laohu8.com/highlight/detail?id=1115611725","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115611725?lang=en_us&edition=fundamental","pubTime":"2026-09-06 19:51","pubTimestamp":1788695476,"startTime":"0","endTime":"0","summary":"Cui Dongshu, secretary general of the China Passenger Car Association, noted that drawing on lessons from the home appliance industry's international expansion, Chinese automakers have developed...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1119","LU0052750758.USD","LU0828238088.HKD","LU0823039010.USD","LU0214875030.USD","SG9999015986.USD","LU0516422440.USD","LU0314109678.HKD","LU1242518931.SGD","LU2580892862.HKD","LU0417516902.SGD","LU0039217434.USD","LU0511384066.AUD","LU0633140727.USD","BK1540","EVS.SI","LU2399975544.HKD","LU0320764243.SGD","LU0261947096.USD","LU2097828631.EUR","LU0348825331.USD","LU1508157978.USD","LU0605514214.HKD","LU2495084118.USD","LU0463099449.HKD","LU0269904917.USD","LU0449509016.USD","LU0143863198.USD","LU1813983027.USD","BYDDY","BK0072","LU0348735423.USD","LU0348827113.USD","LU1251922891.USD","LU0164872284.USD","LU0348766576.USD","LU2476274720.SGD","BK1167","LU0561508036.HKD","LU0865486749.SGD","LU2039709279.SGD","BK1589","LU0251144936.SGD","HYDD.SI","FSXEmain","LU0175139822.USD","LU2663582299.SGD","LU0509642566.USD","LU1808992512.USD","IE00BZ08YS42.EUR","SG9999002828.SGD","SG9999002463.SGD","LU0823414551.USD","LU0029874905.USD","LU0469268626.HKD","LU1064131003.USD","BK1580","LU1820825898.SGD","SG9999006514.SGD","LU0594300419.USD","LU0359201885.HKD","LU2449936058.SGD","LU1146622755.USD","LU0516422366.SGD","LU2357125470.USD","LU2097828805.USD","LU0543330566.HKD","LU2506951792.HKD","LU1720050803.USD","LU2289578879.USD","LU0289960550.SGD","LU0588545490.SGD","SG9999001226.SGD","LU1580142542.USD","LU0164865239.USD","LU0979878070.USD","BK1522","LU0588545904.SGD","LU0588546209.SGD","LU1868837722.USD","BK1539","LU0254981946.USD","LU0516423091.SGD","LU0683595622.HKD","LU1997245094.SGD","LU1064130708.USD","LU2097828557.USD","LU0540923850.HKD","LU0819121731.USD","00285","LU1868837565.USD","SG9999015978.USD","LU1861219969.SGD","BK0155","LU0289961442.SGD","LU0348767384.USD","LU0856984785.SGD","LU0823414478.USD","SMOG","LU0588545730.USD","LU1719994722.HKD","LU0054450605.USD","LU1880383440.USD","LU0593848301.USD","81211","LU0359202008.SGD","LU0449515922.USD","LU0326950275.SGD","LU0708995153.HKD","BK1594","LU2580892789.USD","IE00BZ08YR35.GBP","LU0708995583.HKD","LU2153592121.USD","IE00BZ08YT58.USD","LU1188198961.HKD","LU0650527681.SGD","LU0043850808.USD","LU0128522744.USD","LU1023057109.AUD","LU0244354667.USD","LU0505663152.USD","LU0315178854.USD","LU1868838027.USD","LU0531971595.HKD","LU0823038988.USD","LU0084288322.USD","LU1880383366.USD","LU0516423174.USD","BK0196","LU1770034418.SGD","BK0014","IE00BD6J9T35.USD","BK1610","LU2249611893.SGD","BK0183","LU0823426480.USD","LU2328871848.SGD","BK0264","BK1515","BK1504","01211","LU0516422952.EUR","LU1861214812.USD","LU0327786744.USD","LU1969619763.USD","FDRV","LU2360107325.USD","LU0819123356.HKD","LU2097828474.EUR","LU0594300179.USD","002594","LU2778985437.USD","BK1607","BK0169","LU1242518857.USD","SG9999006597.SGD","SG9999015945.SGD","LU0274383008.USD","LU0417516738.SGD","LU1997244956.HKD","LU1997245177.USD","BK1582","BK0188","BK1149","BK1509","LU2097828714.EUR","LU0307460666.USD","LU1781817850.SGD","LU2348774022.SGD","LU0531970944.HKD","LU0143863784.USD","LU0633140560.USD","LU1328277881.USD","LU2476274308.USD","LU1794554557.SGD","LU0289739343.SGD","LU0871576103.HKD","LU1303224171.USD","LU0211977185.USD","SG9999014674.SGD","LU2294711713.HKD","LU0048597586.USD","LU2148510915.USD","FESXmain","BK0070","LU1961090484.USD","SG9999015952.SGD","LU0320764599.SGD","LU0572944931.SGD","LU0348805143.USD","LU0259732245.USD","LU0359201612.USD","LU0634319403.HKD","LU0165289439.USD","LU0229945570.USD","LU0823426308.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665364504","title":"Shanghai Fosun Pharma 2196.hk Says it Plans to Buy Back up to HK$1Bln of Company H-Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665364504","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665364504?lang=en_us&edition=fundamental","pubTime":"2026-09-06 18:34","pubTimestamp":1788690846,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260906:nL6N44Y02K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0028","BK0187","BK0060","BK0096","BK0183","BK0188","BK0239","BK1515","BK0175","BK0196","BK0012","600196","02196","BK1593","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120592433","title":"Fosun Pharma's Unit to Trim Stake in Gland Pharma via Share Sale","url":"https://stock-news.laohu8.com/highlight/detail?id=1120592433","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120592433?lang=en_us&edition=fundamental","pubTime":"2026-09-06 17:04","pubTimestamp":1788685454,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (600196.SH) has announced that its controlling subsidiary, Fosun Pharma Singapore, executed a share sale of Gland Pharma shares on September 4, 2026...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["600196","BK0183","BK0239","BK1593","BK0187","BK1515","02196","BK0012","BK0060","BK0028","BK0175","BK0196","BK1191","BK0188","BK0096"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129259024","title":"Dizhe Pharma Stock Drops Over 5% After Insider Sell-Off Plan; Company Affirms Long-Term Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=1129259024","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129259024?lang=en_us&edition=fundamental","pubTime":"2026-09-06 15:11","pubTimestamp":1788678679,"startTime":"0","endTime":"0","summary":"Dizhe Pharma (also known as Dizhe Pharmaceutical) saw its share price tumble more than 5% on Thursday, September 4th, following a disclosure that four senior executives plan to reduce their holdings...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","159938","BK1515","BK1574","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1144923293","title":"ALEBUND-B (09637) H Shares Set to Join Stock Connect and Hang Seng Composite Index","url":"https://stock-news.laohu8.com/highlight/detail?id=1144923293","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144923293?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:36","pubTimestamp":1788528973,"startTime":"0","endTime":"0","summary":"The Board of ALEBUND-B (09637) has announced that its H shares have been included in the list of eligible securities under the Stock Connect programme. This inclusion will take effect from Monday,...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","09637","09939","HSCI","BK1574","FLHK","159938","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664204332","title":"Wuhan Dazhong Dental Proposes Wang Hong as Executive Director to Replace Guo Jiaping","url":"https://stock-news.laohu8.com/highlight/detail?id=2664204332","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664204332?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:30","pubTimestamp":1788528637,"startTime":"0","endTime":"0","summary":"Wuhan Dazhong Dental proposes Wang Hong as executive director to replace Guo JiapingWuhan Dazhong Dental Medical proposed appointing vice general manager Wang Hong as an executive director, pending sh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDLbWh1cr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VHT","IE000MB6IJN5.SGD","LU0964807845.USD","LU2471134523.USD","PJP","FHLC","JDOC","LU0345769128.USD","BK1515","LU0820561909.HKD","LU1551013342.USD","XLV","LU0943347566.SGD","IYH","TRUH","02651","GDOC","LU1732799900.SGD","MEDX","LU0234572021.USD","LU1894683264.USD","IXJ","IE00BLSP4239.USD","LU0912757837.SGD","SG9999001440.SGD","JNJ","LU0053666078.USD","LU1244550577.SGD","FTXH","LU0058720904.USD","LU2430703178.SGD","IE00BDGV0183.EUR","LU1061106388.HKD","BMED","LU1894683348.USD","IE00B3T34201.USD","LU2750360997.AUD","IHE","IE00BZ08YR35.GBP","LU2592432038.USD","LU1929549753.HKD","LU0820562030.AUD","LU2430703251.USD","LU0792757196.USD","LU1057294990.SGD","RXL","IE0002141913.USD","01177","LU2756315664.SGD","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185361801","title":"Junshi Biosciences Schedules 2026 Interim Results Conference Call","url":"https://stock-news.laohu8.com/highlight/detail?id=1185361801","media":"Deep News","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185361801?lang=en_us&edition=fundamental","pubTime":"2026-09-04 21:13","pubTimestamp":1788527603,"startTime":"0","endTime":"0","summary":"Junshi Biosciences (also known as JUNSHI BIO) has announced it will hold a conference call to discuss its 2026 interim financial results on September 14, 2026.According to the company's latest...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","01877","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103371342","title":"Traditional Chinese Medicine Firm Secures Regulatory Approval for New Depression Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1103371342","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1103371342?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:54","pubTimestamp":1788526459,"startTime":"0","endTime":"0","summary":"TRAD CHI MED (00570) has announced that its subsidiary, Guizhou Tongjitang Pharmaceutical Co., Ltd., has received official market authorization from the National Medical Products Administration...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570","159992","BK1606","BK1161","BK1191","LNGR","06978","IBBQ","BK1574","BK1515","IPOS","MEDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664334921","title":"China Traditional Chinese Medicine Says NMPA Approves Launch of Xingpi Jieyu Tablets for Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334921","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334921?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:46","pubTimestamp":1788525998,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine says NMPA approves launch of Xingpi Jieyu tablets for depressionChina Traditional Chinese Medicine Holdings said China’s NMPA cleared its Class 1.1 TCM innovative dr","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6dF7Rm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00570","BK1191","BK1606","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664349413","title":"China Traditional Chinese Medicine Holdings - Nmpa Approves Xingpi Jieyu Tablets for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664349413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664349413?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:46","pubTimestamp":1788525987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44W0SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1191","BK1606","00570","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803133","title":"Sinopharm Group Stock Advances 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803133?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:33","pubTimestamp":1788510780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.5% to 15.69 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.4%.Trading volume totaled 9.2 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196","BK0060","BK0175","BK0012","BK0183","BK4175","BK1191","BK0188","BK1197","BK0187","BK0239","BK1515","01099","BK1593","BK0096","BK0028","LU1115378108.SGD","LU0640798160.USD","SHTDY","BK1500","600196","BK0196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138039","title":"JD Health International Stock Rallies 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138039?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:32","pubTimestamp":1788510720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. advanced 2.9% to 37.06 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.JD Health International Inc. closed 48% below its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 7.4 million shares, compared to the 50-day average of 10.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","SGXZ62798434.SGD","LU0456827905.SGD","SGXZ86797644.SGD","BK1142","BK1583","86618","BK1589","06618","BK1571","BK1615","BK1591","LU0051755006.USD","BK1247"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803883","title":"Alibaba Health Information Technology Stock Climbs 3.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803883","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803883?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:31","pubTimestamp":1788510660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. rose 3.3% to 3.14 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.The stock's rise snapped a four-day losing streak.Alibaba Health Information Technology Ltd. closed 60% below its 52-week high of HK$7.91, which the company reached Jan. 14.The stock outperformed some of its competitors, as HKT Trust & HKT Ltd. rose 1.4%.Trading volume totaled 67.4 million shares, compared to the 50-day average of 102.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["07500","HK0000165453.HKD","BK1515","82800","HSTECH","03115","03419","BK1589","83115","07300","HHImain","02833","00241","MHImain","03037","513600","BK1615","BK1247","BK1617","BK1502","MCHmain","BK1189","BK1584","BK1571","07200","09115","BK1610","BK1142","HSI","BK1501","BK1591","02800"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130149343","title":"DBS lifts BYD Electronic price target to HK$40, reiterates 'Buy'","url":"https://stock-news.laohu8.com/highlight/detail?id=1130149343","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130149343?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:26","pubTimestamp":1788510375,"startTime":"0","endTime":"0","summary":"DBS has released a research report stating it has raised the target price for BYD Electronic (00285) from HK$30 to HK$40, while maintaining a \"Buy\" rating. The bank has extended its valuation base to...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1580","BK1607","LU0348766576.USD","BK1515","BK1582","EWH","BK1167","LU0274383008.USD","LU0348767384.USD","00285","BK1589","BK1504","BK1540","BK1149"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183163431","title":"Healthcare Sector Poised for Continued Recovery, Buoyed by Strong Innovation and Upgraded Earnings Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1183163431","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183163431?lang=en_us&edition=fundamental","pubTime":"2026-09-04 15:16","pubTimestamp":1788506182,"startTime":"0","endTime":"0","summary":"According to a research report from BOCOM INTL, the Hong Kong-listed healthcare sector charted an independent course in August, with the Hang Seng Healthcare Index climbing 9.3% against a 1.2%...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","ZECP","09939","159938","BK1161","BK1147","03329","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117075643","title":"Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1117075643","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117075643?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:12","pubTimestamp":1788484341,"startTime":"0","endTime":"0","summary":"According to the latest disclosure from the Hong Kong Stock Exchange, a notable change in share custody was recorded on September 3rd for GENFLEET-B (02595). The total market value of the shares held...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1574","02595","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664028698","title":"Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664028698","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664028698?lang=en_us&edition=fundamental","pubTime":"2026-09-04 06:07","pubTimestamp":1788473269,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group obtained investigational new drug approval for TQB6426 from the U.S. Food and Drug Administration.The drug is intended for advanced malignant tumors, according to a Thursday Hong Kong bourse filing.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1191","01177","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","HK0000165453.HKD","BK1589","IE00BZ08YR35.GBP","BK1521","BK4588","BK4585","LABU","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118066289","title":"Baiyunshan Announces Cash Dividend Distribution for First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1118066289","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118066289?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:41","pubTimestamp":1788446515,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (also known as BAIYUNSHAN PH) disclosed on September 3 that it will execute its interim dividend payout for the 2026 fiscal first...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0097","BK1191","BK0012","BK0070","BK0096","600332","BK0028","BK1521","BK0183","BK1606","BK0188","BK0175","BK0196","BK1197","00874","BK1515","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033874","title":"Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033874","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033874?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:39","pubTimestamp":1788439175,"startTime":"0","endTime":"0","summary":"Sino Biopharm says FDA clears IND for TQB6426 GPC3 ADC trial in advanced tumorsFDA granted IND clearance for TQB6426, a GPC3-targeting antibody-drug conjugate from Sino Biopharmaceutical’s Chia Tai Ti","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL2vynvZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","IE00BZ08YR35.GBP","01177","BK1589","IE00BZ08YS42.EUR","BK1521","BK1191","HK0000165453.HKD","IE00BZ08YT58.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":178,"code":"91000000","status":"200"}]}}